Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017

Detalles Bibliográficos
Autores principales: Albertsson-Lindblad, Alexandra, Palsdottir, Thorgerdur, Smedby, Karin E., Weibull, Caroline E., Glimelius, Ingrid, Jerkeman, Mats
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883541/
https://www.ncbi.nlm.nih.gov/pubmed/34788983
http://dx.doi.org/10.3324/haematol.2021.279037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883541/
https://www.ncbi.nlm.nih.gov/pubmed/34788983
http://dx.doi.org/10.3324/haematol.2021.279037

Ejemplares similares